Skip to content
thispeptide

Shapely

Shapely combines monthly video care with branded and compounded weight-management options. Its public price tabs, membership fee and pharmacy disclosures need to be read together.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

A useful service to investigate for someone wanting recurring clinical contact and help with medication access. Confirm the actual pharmacy, payment cadence and preparation before choosing a package.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Shapely offers medical weight-management care through video visits, provider messaging and pharmacy prescriptions. Its current catalog distinguishes compounded semaglutide and tirzepatide injections from branded options such as Wegovy, Zepbound and oral Foundayo. The membership is a separate care product rather than the medicine itself. A patient can therefore choose between clinically different preparations and payment pathways, but should not assume the same evidence or price applies to all of them. The treating clinician should explain the proposed product and why it fits the patient’s history and treatment goal.

What Shapely prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)Price not published
    • Injection (brand)Price not published
    • Oral (brand)Price not published
  • TirzepatideFDA-approved
    • Injection (compounded)Price not published
    • Injection (brand)Price not published
  • OrforglipronFDA-approved
    • Oral (brand)Price not published

Current compounded semaglutide and tirzepatide pages explicitly identify injections, while separate pages describe approved branded injections and oral medicines. A compounded preparation is not an approved generic equivalent of those brands. The clinician should explain the formulation, titration and monitoring plan, including what changes if insurance does not cover a brand. The medication price also increases across published dose tiers, so clinical adjustments can affect the recurring budget. A lower prepaid equivalent should not influence the clinical pace of titration.

Who prescribes

A licensed clinician

The team page names individual clinicians, including founder Justin Zaghi and medical director Ana Lisa Carr. It also lists other members of the care team. These are public organizational disclosures, not a guarantee that the founder will personally prescribe. The terms identify Zaghi Medical Inc doing business as Shapely, with a New York professional-corporation name in the privacy notice. Ask which clinician and practice will manage the actual plan. The company’s public explanation of professional qualifications is useful context, but the individual clinical relationship still needs to be established.

The service describes an initial provider video visit and monthly clinical check-ins. Ongoing messaging and the companion app support questions and progress tracking between visits. Dietitian access is described for the applicable insurance-backed care arrangement. That can suit someone seeking more continuing contact than an intake-only prescription. Confirm which visits the selected membership includes and which services are billed through insurance. Unlimited chat access should not be confused with unlimited appointments or an immediate prescriber response. New symptoms may still require local examination or other care beyond the remote program.

Are labs required?

Not mentioned

The membership page says laboratory testing is excluded and describes insurance coverage or a possible self-pay charge. That does not establish the same test requirement and frequency for every patient. Ask which baseline results are needed, how often monitoring is required and whether outside reports can be accepted. The provider should explain who acts on abnormal results. A monthly video appointment does not automatically include an unlimited laboratory allowance, and a general testing amount should not be added to every patient’s bill without knowing the actual clinical requirement.

Ready to start with Shapely?

Prices and plans are set on the seller's own site.

What it claims, and what it cites

The public pharmacy FAQ lists BPI, ProRx, VitalRx, Red Rock and OptioRx, while allowing some patient-requested alternatives. Confirm which pharmacy and location will fill the actual prescription. FDA issued ProRx’s Exton facility warning letters in March 2025 and April 2026 concerning compounding and sterile-production practices. The later letter also describes specified tirzepatide and semaglutide recalls from 2025. Those records are relevant to a named partner but do not establish that every Shapely prescription came from that facility or that a particular patient’s medication was affected. The actual pharmacy, lot and current instructions matter more than a general assurance about licensed sourcing.

How it bills

The public Monthly tabs show compounded semaglutide at $139 or $179 and tirzepatide at $249 or $299, depending on dose. The linked help article describes the same amounts per four weeks, while the main tabs use monthly wording. Ask for the actual charge cadence rather than assuming those clocks are identical. Self-pay membership is listed separately at $99 per month, with a first-month promotion. Lower medication headlines belong to prepaid three-month packages. The pharmacy-refund article says compounded orders cannot be canceled or refunded once ordered. Confirm the selected quote and cutoff before authorizing a prescription.

LegitScript: seal displayed on the seller’s site

For and against

  • For: Named medical leadership and recurring video care
  • For: Branded and compounded formats are distinguished
  • For: Public monthly tabs show ordinary medication tiers
  • For: Pharmacy partners and refund limitations are disclosed
  • Against: Membership and medication costs are separate
  • Against: Four-week and monthly price wording need reconciliation
  • Against: Dose increases can change the medication amount
  • Against: A named pharmacy partner has material FDA warning history

The evidence behind what it sells

Right for

Someone wanting recurring video-based weight care who will verify pharmacy assignment, testing needs and the exact treatment budget.

Look elsewhere if

A patient assuming the lowest package equivalent is an independent month or treating pharmacy-network membership as proof that every preparation has the same regulatory history.

Other sellers for weight

Shapely

Frequently asked questions

Is the membership the medication?
No. The public pricing separates care membership from prescription costs, and laboratory testing is also excluded.
Do the main tabs and help center use the same period label?
They show matching amounts but use monthly and per-four-week wording. Confirm the actual medication charge schedule.
Does the ProRx record identify every Shapely prescription as affected?
No. It concerns the named facility and specified conduct or recalled products. Confirm the actual pharmacy and lot for an individual order.

Sources

See what Shapely prescribes today

Shapely sets its own prices, plans and the states it serves. Check them before you start.

Written by Leah Garner from Shapely’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.